Article Text
Therapeutics
Review: erythropoiesis-stimulating agents increase mortality and venous thromboembolism in cancer-associated anaemia
Statistics from Altmetric.com
Footnotes
Source of funding: National Cancer Institute and National Heart, Lung and Blood Institute.
Footnotes
*See recent FDA amendment (www.fda.gov/medwatch/safety/2008/safety08.htm#ESAZ).